{"product_id":"tesamorelin-10mg-pharmatech","title":"Tesamorelin 10mg (Liofilizada) + Água Bacteriostática - PharmaTech","description":"\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eO \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eTesamorelin 10mg – PharmaTech\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e é um peptídeo sintético análogo do \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eGHRH (Growth Hormone-Releasing Hormone)\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, estudado principalmente em pesquisas relacionadas ao eixo \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eGHRH–GH–IGF-1\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, metabolismo do tecido adiposo e composição corporal.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eDiferentemente da administração direta de hormônio do crescimento, o Tesamorelin atua estimulando a liberação \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eendógena de GH\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e pela hipófise, aumentando posteriormente os níveis de \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eIGF-1\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSeu principal campo de pesquisa envolve a \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003egordura visceral abdominal\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, além de estudos sobre metabolismo, distribuição de gordura e alterações na composição corporal.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003ePrincipais benefícios e destaques\u003c\/span\u003e\u003c\/h2\u003e\n\u003cul data-spread=\"false\"\u003e\n\u003cli\u003e\u003cspan\u003e10mg de Tesamorelin por frasco\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eAnálogo sintético de GHRH\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eEstimula a secreção endógena de GH\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eRelacionado ao aumento de IGF-1\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ePesquisa em gordura visceral abdominal\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eEstudos sobre composição corporal\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eInvestigação do tecido adiposo\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ePesquisa sobre metabolismo lipídico\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eEstudos sobre distribuição de gordura corporal\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eInvestigação do eixo GHRH–GH–IGF-1\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eApresentação PharmaTech\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch1\u003e\u003cspan\u003eO que é o Tesamorelin?\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eO \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eTesamorelin\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e é um análogo sintético do \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003ehormônio liberador do hormônio do crescimento (GHRH)\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSeu mecanismo está relacionado à estimulação da hipófise para aumentar a secreção natural de \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eGH\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, que por sua vez participa da produção e regulação de \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eIGF-1\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eEssa característica diferencia o Tesamorelin de produtos que fornecem diretamente o hormônio do crescimento.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eO principal uso clínico aprovado da tesamorelina nos Estados Unidos está relacionado à redução do excesso de gordura abdominal em adultos com HIV e lipodistrofia.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eTesamorelin e o eixo GH–IGF-1\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eO eixo hormonal envolvido pode ser representado de maneira simplificada:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eGHRH → GH → IGF-1\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eO Tesamorelin funciona como um análogo do GHRH, estimulando a liberação de GH endógeno.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eO aumento da secreção de GH produz alterações subsequentes na sinalização do \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eIGF-1\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, tornando o eixo GH–IGF-1 uma das principais áreas de interesse científico do composto.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eEnsaios clínicos demonstraram aumento de IGF-1 associado ao tratamento com tesamorelina.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eTesamorelin e gordura visceral\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eA \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003egordura visceral abdominal\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e é uma das principais áreas de pesquisa relacionadas à tesamorelina.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eEm estudos clínicos com indivíduos com HIV e acúmulo de gordura abdominal, a tesamorelina produziu reduções significativas na quantidade de tecido adiposo visceral.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eEm um estudo randomizado envolvendo 404 participantes, a gordura visceral diminuiu aproximadamente 10,9% após seis meses de tratamento, enquanto não houve redução significativa da gordura subcutânea abdominal.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eEssa característica é importante porque demonstra uma diferença entre \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003egordura visceral\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e e simplesmente redução do peso corporal.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eComposição corporal\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eA composição corporal envolve diferentes compartimentos, incluindo:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul data-spread=\"false\"\u003e\n\u003cli\u003e\u003cspan\u003eGordura visceral\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eGordura subcutânea\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eMassa magra\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eMassa muscular\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eGordura hepática\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eA pesquisa com Tesamorelin concentra-se especialmente na alteração da distribuição da gordura visceral.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eUma meta-análise publicada em 2026, reunindo cinco ensaios clínicos randomizados em adultos com HIV, encontrou redução significativa de gordura visceral, gordura de tronco e gordura hepática, além de aumento de massa magra; não foi observada redução significativa do IMC ou da gordura subcutânea.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eMetabolismo do tecido adiposo\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eO eixo do hormônio do crescimento possui importante relação com o metabolismo energético e o tecido adiposo.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003ePor isso, o Tesamorelin é estudado em diferentes aspectos relacionados a:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul data-spread=\"false\"\u003e\n\u003cli\u003e\u003cspan\u003eMetabolismo lipídico\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eMobilização de gordura\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eTecido adiposo visceral\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eDistribuição de gordura\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eComposição corporal\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eSinalização hormonal\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eMetabolismo energético\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eEstudos em indivíduos com obesidade abdominal e secreção reduzida de GH também investigaram os efeitos da tesamorelina sobre gordura visceral e marcadores metabólicos.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eTesamorelin e IGF-1\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eO \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eIGF-1 (Insulin-like Growth Factor 1)\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e é um dos principais marcadores associados à atividade do eixo GH.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eComo análogo de GHRH, o Tesamorelin estimula a produção endógena de GH, levando ao aumento de IGF-1.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eEsse efeito é consistentemente observado nos estudos clínicos e representa uma importante medida farmacodinâmica do composto.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eTesamorelin não é GH\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eUma diferença fundamental é o mecanismo de ação.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eTesamorelin\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eÉ um \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eanálogo de GHRH\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e que estimula a produção e liberação endógena de GH.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eSomatropina\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eÉ o próprio \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003ehormônio do crescimento humano recombinante (GH)\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e administrado diretamente.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003ePortanto, Tesamorelin e somatropina são moléculas diferentes e atuam em pontos diferentes do eixo hormonal.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eTesamorelin e gordura abdominal\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eA gordura abdominal apresenta diferentes compartimentos.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eGordura visceral:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e localizada ao redor dos órgãos dentro da cavidade abdominal.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eGordura subcutânea:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e localizada logo abaixo da pele.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eA pesquisa clínica com Tesamorelin demonstra um efeito particularmente direcionado à \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003egordura visceral\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, sem a mesma magnitude de redução observada na gordura subcutânea abdominal.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eEsse perfil é um dos principais diferenciais científicos do composto.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eTesamorelin e metabolismo hepático\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eAlém da gordura visceral, pesquisas também investigaram a relação entre tesamorelina e \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003egordura hepática\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eEm um ensaio clínico randomizado com pacientes com HIV e acúmulo de gordura abdominal, seis meses de tesamorelina produziram redução significativa da gordura hepática em comparação com placebo.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eA meta-análise mais recente também encontrou redução significativa da gordura hepática nos estudos avaliados.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003ePesquisas sobre composição corporal\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eO Tesamorelin apresenta interesse científico em estudos relacionados a:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul data-spread=\"false\"\u003e\n\u003cli\u003e\u003cspan\u003eGordura visceral\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eGordura hepática\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eGordura de tronco\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eMassa magra\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eCircunferência abdominal\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eDistribuição de gordura\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIGF-1\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eMetabolismo lipídico\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eA literatura indica que seus efeitos sobre composição corporal não devem ser confundidos com uma simples redução generalizada do peso ou do IMC.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eDiferencial do Tesamorelin 10mg – PharmaTech\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eO principal diferencial do Tesamorelin está em sua atuação sobre o eixo \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eGHRH–GH–IGF-1\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e e no histórico de pesquisa clínica relacionado à \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003egordura visceral abdominal\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eEntre os principais destaques:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul data-spread=\"false\"\u003e\n\u003cli\u003e\u003cspan\u003e10mg por frasco\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eAnálogo de GHRH\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eEstímulo da secreção endógena de GH\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eAumento de IGF-1\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eEstudos clínicos sobre gordura visceral\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ePesquisa em composição corporal\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eEstudos relacionados à gordura hepática\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eInvestigação do metabolismo lipídico\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eProduto PharmaTech\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch1\u003e\u003cspan\u003ePrincipais áreas de pesquisa\u003c\/span\u003e\u003c\/h1\u003e\n\u003ch3\u003e\u003cspan\u003eGHRH–GH–IGF-1\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003ePesquisa da estimulação endógena do hormônio do crescimento e seus efeitos posteriores.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eGordura visceral\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eUma das principais áreas de investigação clínica do Tesamorelin.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eComposição corporal\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eEstudos relacionados à distribuição de gordura e massa magra.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eMetabolismo lipídico\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eInvestigação de alterações em lipídios e metabolismo do tecido adiposo.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eGordura hepática\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eEstudos envolvendo a relação entre tesamorelina e acúmulo de gordura no fígado.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eTecido adiposo\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003ePesquisa sobre diferentes compartimentos de gordura corporal.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eEndocrinologia\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eInvestigação do funcionamento do eixo hipotálamo–hipófise–GH.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eInformações do produto\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eProduto:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Tesamorelin\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eConcentração:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e 10mg\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eMarca:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e PharmaTech\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eCategoria:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Peptídeos \/ GHRH\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eClasse:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Análogo de GHRH\/GHRF\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eMecanismo principal:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Estimulação da secreção endógena de GH\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eEfeito farmacodinâmico:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Aumento de IGF-1\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eApresentação:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Frasco com peptídeo liofilizado\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003ePrincipais áreas de pesquisa:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Gordura visceral, composição corporal, metabolismo e eixo GH–IGF-1\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003ePor que escolher o Tesamorelin 10mg – PharmaTech?\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eO \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eTesamorelin 10mg – PharmaTech\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e reúne uma apresentação concentrada de um peptídeo com extensa literatura clínica relacionada ao eixo \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eGHRH–GH–IGF-1\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSeu principal diferencial científico é a pesquisa direcionada à \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003egordura visceral\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, com estudos também envolvendo composição corporal, gordura hepática, metabolismo lipídico e massa magra.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eA apresentação de \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e10mg por frasco\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e oferece uma opção intermediária para pesquisas com Tesamorelin.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003ePerguntas frequentes\u003c\/span\u003e\u003c\/h1\u003e\n\u003ch3\u003e\u003cspan\u003eO que é Tesamorelin?\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eTesamorelin é um \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eanálogo sintético de GHRH\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, estudado principalmente por sua capacidade de estimular a secreção endógena de GH.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eTesamorelin aumenta GH?\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSim. O Tesamorelin estimula a secreção de GH pela hipófise e, consequentemente, aumenta os níveis de IGF-1.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eTesamorelin é GH?\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eNão. Tesamorelin é um análogo de GHRH; o GH recombinante, como a somatropina, é o próprio hormônio do crescimento.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eTesamorelin está relacionado à gordura visceral?\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSim. A redução da gordura visceral abdominal é a principal área de eficácia clínica estabelecida para a tesamorelina na indicação aprovada nos EUA.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eTesamorelin reduz gordura subcutânea?\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eOs estudos clínicos não demonstraram o mesmo efeito sobre a gordura subcutânea abdominal observado sobre a gordura visceral.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eTesamorelin aumenta IGF-1?\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSim. O aumento de IGF-1 é uma resposta farmacodinâmica característica da estimulação do eixo GH pela tesamorelina.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eQual a diferença entre Tesamorelin 10mg e 20mg?\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eA principal diferença é a quantidade total de peptídeo no frasco: \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e10mg nesta apresentação e 20mg na apresentação de maior concentração\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eQual é a apresentação do produto?\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eO \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eTesamorelin 10mg – PharmaTech\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e é apresentado em frasco contendo \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e10mg de peptídeo liofilizado\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eTesamorelin 10mg – PharmaTech\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eO \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eTesamorelin 10mg – PharmaTech\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e é um peptídeo de alto interesse em pesquisas endocrinológicas e metabólicas, especialmente por sua atuação como análogo de \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eGHRH\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e e sua capacidade de estimular o eixo \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eGH–IGF-1\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eCom extensa investigação clínica sobre \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003egordura visceral abdominal\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, o composto também é estudado em composição corporal, metabolismo lipídico, gordura hepática e distribuição de tecido adiposo.\u003c\/span\u003e\u003c\/p\u003e","brand":"PharmaTech","offers":[{"title":"Default Title","offer_id":44326086934587,"sku":"PTECH-TESA10","price":749.9,"currency_code":"BRL","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/9952\/8251\/files\/tesamorelin-10mg-liofilizada-agua-bacteriostatica-pharmatech-465.webp?v=1790716585","url":"https:\/\/peptideosdobrasil.com.br\/products\/tesamorelin-10mg-pharmatech","provider":"Peptideos do Brasil","version":"1.0","type":"link"}